The Ohio State University College of Pharmacy is now offering a second 1-hour Continuing Education (CE) course presented by OSU professor and ASBM Advisory Board Chair Philip Schneider, FASHP, FFIP.
The course is entitled “Biosimilar Substitution and Interchangeability”, and discusses how biosimilars are substituted at the pharmacy level in the U.S., and contrasts U.S. practices with those in other countries. The course also examines patient and physician concerns with non-medical switching, and explains the U.S.-specific concept of interchangeability. The course is ACPE accredited and available to pharmacists nationwide.
The course is the second in a series on biosimilars presented by the College of Pharmacy’s Office of Continuing Professional Development. Future course entries will examine topics including biologic pharmacovigilance and nomenclature, physician and patient perspectives on biosimilars, and the biosimilars market.
View the latest OSU CE course, “Biosimilar Substitution and Interchangeability”, here. (registration required).
View the first OSU CE Course, Biologics and Biosimilars: and Introduction, here (registration required).
Visit the OSU College of Pharmacy’s Office of Continuing Professional Development here.